Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Eppendorf SE and DataHow AG announce strategic collaboration to advance bioprocess data management
Tuesday, December 03, 2024Eppendorf SE a leading life science company and DataHow AG a pioneer in advanced data analytics and AIdriven prediction software are excited to announce a strategic collaboration aimed at transforming bioprocess development This partnership will inte...
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea
Thursday, November 28, 2024Eisai Co Ltd and Biogen Inc announced today that the humanized antisoluble aggregated amyloidbeta A monoclonal antibody LEQEMBI has been launched in South Korea LEQEMBI received the Ministry of Food and Drug Safety MFDS approval in May for treatment...
Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer
Wednesday, November 27, 2024Anocca AB a leading Tcell receptorengineered Tcell TCRT cellular therapeutics company announces the submission of its first Clinical Trial Application CTA to the European Medicines Agency EMA for a Phase III multiasset umbrella trial VIDAR The VIDAR...
Greenwich LifeSciences Partners with GIM in Italy
Wednesday, November 27, 2024Greenwich LifeSciences Inc a clinicalstage biopharmaceutical company focused on its Phase III clinical trial FLAMINGO which is evaluating GLSI an immunotherapy to prevent breast cancer recurrences today announced its partnership with clinical sites i...
Lundbeck initiates a phase III trial with amlenetug for the treatment of Multiple System Atrophy
Wednesday, November 27, 2024H Lundbeck AS Lundbeck today announced the advancement of the clinical development of amlenetug Lu AF for the treatment of MSA with the initiation of MASCOT a randomized doubleblind phase III trial
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Monday, November 25, 2024Positive highlevel results from the CAPItello Phase III trial showed that AstraZenecas Truqap capivasertib in combination with abiraterone and androgen deprivation therapy ADT demonstrated a statistically significant and clinically meaningful improve...
NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Improve and Accelerate Gene Therapy Development
Friday, November 22, 2024NewBiologix a technology innovation company pioneering tools for efficient costeffective and scalable production of viral vectors for gene and cell therapy has launched its Xcell rAAV Production and Analytics Platform Xcell rAAV Platform designed to...
Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a Groundbreaking Gene Therapy for Wet AMD Including PCV
Friday, November 22, 2024Avirmax Biopharma Inc a leader in the development of innovative gene therapies today announced that the first patient has been successfully dosed in the Phase IIIa clinical trial of ABI the companys first gene therapy drug for the treatment of Wet Ag...
London Lab Live 2025 – The UK's Premier Event for the Lab Community
Friday, November 22, 2024London Lab Live is set to debut on May at ExCeL London bringing together professionals from across the lab sector to inspire collaboration and innovation Representing industries such as chemical and material science
Vetter Strengthens Senior Management Team for Further Sustainable Growth
Thursday, November 21, 2024Vetter a globally operating Contract Development and Manufacturing Organization CDMO has announced the appointment of three senior leaders to take on the role of comanaging directors alongside Thomas
